Search clinical trials for: MEDI3617

Total 9 results

Novo Nordisk A/S

Terminated

Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

United States, Germany, United Kingdom
MedImmune LLC
Department of Health and Human Services

Completed

A Study to Evaluate the Safety of H1N1 Monovalent Vaccine (MEDI3414) in Healthy Adults (MI-CP215)

Healthy

United States
F. Stephen Hodi, MD
MedImmune LLC

Completed

Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma

Metastatic Melanoma

United States
AstraZeneca

Completed

A Study of the Safety, Tolerability and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Chronic Pain

Germany
TTY Biopharm

Unknown

Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

Taiwan
AstraZeneca
Parexel

Completed

A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease

Chronic Kidney Disease

United States
MedImmune LLC
Department of Health and Human Services

Completed

A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age (MI-CP217)

Influenza

United States
AstraZeneca

Completed

Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Chronic Pain

Germany
MedImmune LLC

Completed

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

Advanced Solid Tumors | Advanced Recurrent Ovarian Tumors

United States

3

Subscribe